Clinical Cancer Research, Vol 4, Issue 10 2419-2424, Copyright © 1998 by American Association for Cancer Research

ARTICLES

Expression of cadherin-6 as a novel diagnostic tool to predict prognosis of patients with E-cadherin-absent renal cell carcinoma

T Shimazui, E Oosterwijk, H Akaza, P Bringuier, E Ruijter, H van Berkel, JO Wakka, A van Bokhoven, FM Debruyne and JA Schalken
Department of Urology, Institute of Clinical Medicine, University of Tsukuba, Ibaraki, Japan.

In many carcinomas, E-cadherin is considered to be a prognostic marker for patient survivals, and its decreased expression is associated with metastatic disease. Among renal cell carcinomas (RCCs), however, only 20% of tumors express E-cadherin, whereas a much higher percentage express other cadherins, e.g., N-cadherin and cadherin-6 (T. Shimazui et al, Cancer Res., 56: 3234-3237, 1996). Among these cadherins expressed in RCCs, cadherin-6 has been identified as a major cadherin in the renal proximal tubules and in the tumors themselves. Hence, we have investigated the relationship between prognosis and cadherin-6 expression in tumor cells in 43 patients with RCC. Expression of cadherin-6, E-cadherin, and alpha-catenin was detected immunohistochemically and evaluated microscopically as normal, heterogeneous, or absent. Normal, heterogeneous, and absent expression of cadherin-6 were observed in 19, 16, and 8 of 43 cases, respectively. Coexpression of E-cadherin and cadherin-6 was detected in only 10 cases. Among 30 tumors in which E-cadherin expression was absent, 24 expressed cadherin-6. In addition, the expression pattern of alpha-catenin correlated more highly with that of cadherin-6 than it did with E-cadherin (P = 0.0003 versus 0.025). In survival analyses, aberrant expression of cadherin-6 correlated with poor survivals both among all patients (P = 0.0009) and in those with E-cadherin-absent RCC (P = 0.0008). These results suggest that cadherin-6 is a major cadherin playing an essential role in cell-cell adhesion in E-cadherin-absent RCC.

This article has been cited by other articles:

				Y. Allory, Y. Matsuoka, C. Bazille, E. I. Christensen, P. Ronco, and H. Debiec The L1 Cell Adhesion Molecule Is Induced in Renal Cancer Cells and Correlates with Metastasis in Clear Cell Carcinomas Clin. Cancer Res., February 1, 2005; 11(3): 1190 - 1197. [Abstract] [Full Text] [PDF]

				R. H. Thompson, M. D. Gillett, J. C. Cheville, C. M. Lohse, H. Dong, W. S. Webster, K. G. Krejci, J. R. Lobo, S. Sengupta, L. Chen, et al. Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target PNAS, December 7, 2004; 101(49): 17174 - 17179. [Abstract] [Full Text] [PDF]

				G. Li, M. Cuilleron, A. Gentil-Perret, M. Cottier, K. Passebosc-Faure, C. Lambert, C. Genin, and J. Tostain Rapid and Sensitive Detection of Messenger RNA Expression for Molecular Differential Diagnosis of Renal Cell Carcinoma Clin. Cancer Res., December 15, 2003; 9(17): 6441 - 6446. [Abstract] [Full Text] [PDF]

				G. C. Sellar, L. Li, K. P. Watt, B. D. Nelkin, G. J. Rabiasz, E. A. Stronach, E. P. Miller, D. J. Porteous, J. F. Smyth, and H. Gabra BARX2 Induces Cadherin 6 Expression and Is a Functional Suppressor of Ovarian Cancer Progression Cancer Res., October 1, 2001; 61(19): 6977 - 6981. [Abstract] [Full Text] [PDF]